Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

New paper-based technology could lead to earlier detection of cancer

Washington State University researchers have developed a technology that is more than 30 times more sensitive than current lab-based tests in finding early stage cancer biomarkers in blood.

4 Jun 2020

World’s first study of potential antibody therapy to fight COVID-19 begins in humans

Eli Lilly and Company today announced patients have been dosed in the world’s first study of a potential antibody treatment designed to fight COVID-19.

4 Jun 2020

Pre-clinical data for Celltrion’s antiviral antibody treatment shows 100-fold reduction in viral load of SARS-CoV-2

Celltrion Group today announced positive pre-clinical results for its COVID-19 antiviral antibody treatment, with data demonstrating a 100-fold reduction in the viral load of SARS-CoV-2, the virus causing COVID-19.

4 Jun 2020

AFFiRiS announces preclinical results of monoclonal antibody mAB C6-17 in Huntington's

AFFiRiS, a clinical-stage biotechnology company developing novel disease-modifying specific active immunotherapies, today announced that detailed preclinical results with its monoclonal antibody mAB C6-17 to treat Huntington's Disease were published in the peer-reviewed journal Neurobiology of Disease.

3 Jun 2020

Kawasaki-like inflammatory syndrome appears to be more common in children of African ancestry

An inflammatory syndrome in children and adolescents, believed to be linked to covid-19, seems to be more common among children of African ancestry, finds a small study from a hospital in Paris, published by The BMJ today.

3 Jun 2020

Hype collides with science as FDA tries to rein in ‘Wild West’ of COVID blood tests

"Save your business while saving lives," reads the website of Because Health, a Seattle tech startup selling two types of tests to employers willing to pay $350 a pop to learn whether their workers have been infected with COVID-19.

3 Jun 2020

New drug can prevent life-threatening anaphylaxis, shows study

For someone with a food or drug allergy, the risk of life-threatening anaphylactic shock lurks around every corner. A new Northwestern Medicine study shows there might be a pill that can be taken proactively to prevent mild to life-threatening anaphylaxis, no matter the cause.

3 Jun 2020

Convalescent plasma therapy improves outcomes in majority of COVID-19 patients

First peer-reviewed publication on US trial results from Houston Methodist published in The American Journal of Pathology

3 Jun 2020

Siemens receives FDA approval for SARS-CoV-2 antibody test

Siemens Healthineers has announced that the U.S. Food and Drug Administration (FDA) had issued an Emergency Use Authorization for its total antibody test to detect the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies, including Immunoglobulin M (IgM) and Immunoglobulin G (IgG) in the blood.

3 Jun 2020

Scientists to develop device to identify neutralizing antibodies against SARS-CoV-2 infection

A Texas A&M University team of scientists and engineers is leading the development of a device that can be used to rapidly identify antibodies produced by human B cells that can neutralize infection by SARS-CoV-2, the causative agent of COVID-19.

2 Jun 2020

Alternative model addresses the shortcomings of neutrophil-depletion model

s the COVID-19 pandemic continues to spread, researchers are turning their attention to the virus' biology, mechanism of action, and possible treatments. One of the targets are a group of immune cells called "neutrophils", which have been reported to infiltrate the respiratory tract of patients who have died from COVID-19.

2 Jun 2020

At-home finger prick COVID-19 antibody testing

The best way to estimate the actual prevalence of COVID-19 in the population is by antibody testing. A new study by scientists at Enable Biosciences and published on the preprint server medRxiv* in May 2020 reports the development of fast and sensitive antibody testing kits designed for at-home use. This could significantly boost the measurement of population prevalence of this infection and help understand whether it confers immunity to reinfection.

2 Jun 2020

SARS-CoV-2 started spreading in the United States in January, CDC says

The United States has reported the highest number of infections across the globe, with more than 1.81 million confirmed cases and at least 105,000 deaths. The magnitude of the novel coronavirus spread hints that the virus may have started earlier than previously thought.

2 Jun 2020

Reducing inflammation improves stroke recovery, may extend window for therapy

Reperfusion therapy, the gold standard for stroke treatment, helps restore blood flow after a stroke caused by a clot, preventing loss of brain tissue. However, only about 10% of stroke patients qualify, in part because of reperfusion therapy's narrow treatment window.

1 Jun 2020

SARS-CoV-2 prevalence varies widely across Brazil

Researchers have shown that the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Brazil varies significantly by city and region, with the highest prevalence observed in the North of the country and the lowest seen in South and Center-West regions.

1 Jun 2020

Significant number of COVID-19 positive cases asymptomatic, raising transmission concerns

There have been many instances of people testing positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who have no symptoms of the infection whatsoever. These asymptomatic patients are, however, still capable of spreading the infection without being aware of it, say experts.

31 May 2020

Developing an international consortium to improve clinical decision-making in Hodgkin lymphoma

A harmonization of 'big data' in examining long-term outcomes with contemporary treatment for pediatric and adult Hodgkin lymphoma patients is yielding a new approach to inform future clinical trial design and enhance clinical decision-making.

30 May 2020

Monoclonal antibody therapy achieves modest reduction in recurrence for patients with HER2-positive DCIS

The addition of the monoclonal antibody therapy Trastuzumab to radiotherapy did not reach the protocol objective of a 36% reduction in the ipsilateral breast tumor recurrence rate for women with HER2-positive ductal carcinoma in situ (DCIS) on the NRG Oncology clinical trial NSABP B-43.

29 May 2020

Addition of monoclonal antibody to trimodality therapy offers no benefit in HER2 over expressing esophageal cancer

Results of the NRG Oncology clinical trial RTOG 1010 indicated that the addition of the monoclonal antibody trastuzumab to neoadjuvant trimodality treatment did not improve disease-free survival outcomes for patient with HER2 overexpressing local and locally advanced esophageal adenocarcinoma.

29 May 2020

Blood test offers new opportunities to improve malarial control and elimination strategies

Plasmodium vivax is the most widespread malaria parasite worldwide, with up to two billion people at risk of infection.

29 May 2020

Antibody News and Research

Further Reading

New paper-based technology could lead to earlier detection of cancer

World’s first study of potential antibody therapy to fight COVID-19 begins in humans

Pre-clinical data for Celltrion’s antiviral antibody treatment shows 100-fold reduction in viral load of SARS-CoV-2

AFFiRiS announces preclinical results of monoclonal antibody mAB C6-17 in Huntington's

Kawasaki-like inflammatory syndrome appears to be more common in children of African ancestry

Hype collides with science as FDA tries to rein in ‘Wild West’ of COVID blood tests

New drug can prevent life-threatening anaphylaxis, shows study

Convalescent plasma therapy improves outcomes in majority of COVID-19 patients

Siemens receives FDA approval for SARS-CoV-2 antibody test

Scientists to develop device to identify neutralizing antibodies against SARS-CoV-2 infection

Alternative model addresses the shortcomings of neutrophil-depletion model

At-home finger prick COVID-19 antibody testing

SARS-CoV-2 started spreading in the United States in January, CDC says

Reducing inflammation improves stroke recovery, may extend window for therapy

SARS-CoV-2 prevalence varies widely across Brazil

Significant number of COVID-19 positive cases asymptomatic, raising transmission concerns

Developing an international consortium to improve clinical decision-making in Hodgkin lymphoma

Monoclonal antibody therapy achieves modest reduction in recurrence for patients with HER2-positive DCIS

Addition of monoclonal antibody to trimodality therapy offers no benefit in HER2 over expressing esophageal cancer

Blood test offers new opportunities to improve malarial control and elimination strategies

Accelerating therapeutic antibody discovery and development eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo